Jump to content
  • Sign Up
0
Scott Adams

ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic ... - PR Newswire (press release)

Rate this topic

Recommended Posts

ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic ...

PR Newswire (press release)

"ImmusanT's Nexvax2 and companion diagnostic address the rapidly growing number of patients diagnosed with celiac disease whose only option is a strict diet that eliminates gluten. At Vatera we seek to invest in therapies that fulfill unmet medical ...

and more »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×